Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992939 | SCV001145552 | uncertain significance | not provided | 2019-04-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327219 | SCV002632012 | uncertain significance | Inborn genetic diseases | 2021-05-28 | criteria provided, single submitter | clinical testing | The p.R1473C variant (also known as c.4417C>T), located in coding exon 8 of the SETX gene, results from a C to T substitution at nucleotide position 4417. The arginine at codon 1473 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant juvenile amyotrophic lateral sclerosis 4 (ALS4); however, its contribution to the development of autosomal recessive spinocerebellar ataxia with axonal neuropathy 2 (SCAN2). is uncertain. |
Genome- |
RCV003233895 | SCV003931376 | uncertain significance | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233896 | SCV003931379 | uncertain significance | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing |